The global in vitro diagnostic (IVD) quality controls market is estimated to reach USD 1.04 billion by 2022, at a CAGR of 3.5% during the forecast period. Some of the factors driving the growth of the IVD quality controls market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls.
In this report, the market is segmented by product and service, application, end user, manufacturer type, and region. On the basis of application, the IVD quality controls market is broadly segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, microbiology, coagulation/hemostasis, and other applications. Among these, the immunochemistry segment accounted for the largest share of the IVD quality control applications market in 2016. This large share of the immunoassay segment can be attributed to their increased use in diagnosis over conventional methods, as they ensure precise and accurate test results and help minimize laboratory errors.
However, the molecular diagnostics segment is projected to grow at the highest CAGR during the forecast period. The rising prevalence of infectious diseases along with increase in IVD tests to diagnose these diseases will ultimately stimulate the need for quality controls to validate test results is expected to propel the growth of this segment.
Download PDF Brochure :http://www.marketsandmarkets.com/pdfdownload.asp?id=198032582
Based on the manufacturer type, the IVD quality controls market is majorly segmented into third-party control manufacturers and OEMs. Among these, the third-party control manufacturers segment accounted for the largest share of the global market in 2016. The large share of this segment is attributed to the increasing use of third-party quality controls across the globe to verify patient test results.
In 2016, North America commanded the largest share of the IVD quality controls market, followed by Europe. Although North America will continue to be the largest market for IVD quality controls, the Asia-Pacific (APAC) region is expected to witness the highest growth rate during the forecast period. Asian countries, particularly China and India, are expected to offer significant growth opportunities for independent manufacturers of quality controls as well as IVD instrument and reagent manufacturers. The high growth in these markets can be attributed to the significant demand for high quality, accurate diagnostic tests from the large patient population. Also, with developed economies reaching saturation, manufacturers and suppliers are expected to focus on the Asian market.